| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3281352 | Clinical Gastroenterology and Hepatology | 2015 | 31 Pages |
Abstract
Addition of curcumin to mesalamine therapy was superior to the combination of placebo and mesalamine in inducing clinical and endoscopic remission in patients with mild-to-moderate active UC, producing no apparent adverse effects. Curcumin may be a safe and promising agent for treatment of UC. Clinicaltrials.gov number: NCT01320436.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Alon Lang, Nir Salomon, Justin C.Y. Wu, Uri Kopylov, Adi Lahat, Ofir Har-Noy, Jessica Y.L. Ching, Pui Kuan Cheong, Benjamin Avidan, Dorit Gamus, Ioannis Kaimakliotis, Rami Eliakim, Siew C. Ng, Shomron Ben-Horin,